Invention Grant
- Patent Title: Pharmaceutical compounds
-
Application No.: US16341631Application Date: 2017-10-18
-
Publication No.: US10696666B2Publication Date: 2020-06-30
- Inventor: Neil Anthony Pegg , Stuart Thomas Onions , David Michel Adrien Taddei , Jonathan Shannon , Silvia Paoletta , Richard James Brown , Don Smyth , Gareth Harbottle
- Applicant: CELLCENTRIC LTD
- Applicant Address: GB Cambridge
- Assignee: CELLCENTRIC LIMITED
- Current Assignee: CELLCENTRIC LIMITED
- Current Assignee Address: GB Cambridge
- Agency: MH2 Technology Law Group, LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@7deb542e
- International Application: PCT/GB2017/053152 WO 20171018
- International Announcement: WO2018/073586 WO 20180426
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D417/14 ; C07D413/14 ; A61K45/06
Abstract:
A compound which is an arylimidazolyl isoxazole of formula (I): (Formula (I)) or a pharmaceutically acceptable salt thereof. The compound has activity in modulating the activity of p300 and/or CBP and is used to treat cancer, particularly prostate cancer.
Public/Granted literature
- US20190375740A1 PHARMACEUTICAL COMPOUNDS Public/Granted day:2019-12-12
Information query
